Merger | CHR HAN-SPON ADR & NOVOZYMES A/S ADR | 29th February 2024

Initially announced on December 12, 2022, NOVOZYMES AS CLASS B made a stock offer for CHR HANSEN HOLDING AS of 1.5326 shares per CHR HANSEN HOLDING AS share held. The Merger was completed on January 31, 2024. As a result of the completed Merger, JPMorgan, as depositary, has sold the NOVOZYMES AS CLASS B shares that represented CHR HAN-SPON ADR and converted the net proceeds from such sale into U.S. dollars. The ADR program will be terminated effective February 27, 2024 and holders of CHR HAN-SPON ADR must surrender their ADRs for cancellation in order to receive payment of the termination proceeds. The final cash distribution rate per DR is confirmed as USD 19.4566628.

• CHR HAN-SPON ADR will be removed from the Index.
• The weight of CHR HAN-SPON ADR (CHYHY.PK) based on its last close price will be distributed pro rata to remaining Index constituents.
• Effective Date (open): 29/02/2024

Solactive GBS DM ex North America Large & Mid Cap US Listings USD Index NTR
Solactive GBS DM ex North America Large & Mid Cap US Listings USD Index PR
Solactive GBS DM ex North America Large & Mid Cap US Listings USD Index TR